111 related articles for article (PubMed ID: 2703390)
41. Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivo.
Busutti L; Breccia A; Ferri E; Falcone F; Bertoni F
Int J Radiat Oncol Biol Phys; 1992; 22(3):585-8. PubMed ID: 1531219
[TBL] [Abstract][Full Text] [Related]
42. Quantitative evaluation of the murine B16 melanoma tumor model after gene marking with an EGFP/Neo expressing retroviral vector.
Hansen BD; Duch M; Hokland P; Pedersen FS; Hokland M
In Vivo; 2002; 16(3):167-74. PubMed ID: 12182111
[TBL] [Abstract][Full Text] [Related]
43. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
44. Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
Kubota R; Yamada S; Ishiwata K; Tada M; Ido T; Kubota K
Br J Cancer; 1993 Apr; 67(4):701-5. PubMed ID: 8471428
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics and subcellular localization of radiosensitizers.
Stratford MR
BJR Suppl; 1992; 24():100-4. PubMed ID: 1290683
[No Abstract] [Full Text] [Related]
46. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
Brown JM
Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
[No Abstract] [Full Text] [Related]
47. Inhibitory components from the buds of clove (Syzygium aromaticum) on melanin formation in B16 melanoma cells.
Arung ET; Matsubara E; Kusuma IW; Sukaton E; Shimizu K; Kondo R
Fitoterapia; 2011 Mar; 82(2):198-202. PubMed ID: 20858534
[TBL] [Abstract][Full Text] [Related]
48. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
49. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
[TBL] [Abstract][Full Text] [Related]
50. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro.
Watts ME; Dennis MF; Woodcock M
Br J Radiol; 1987 Dec; 60(720):1233-5. PubMed ID: 2961396
[No Abstract] [Full Text] [Related]
51. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.
Mannan RH; Mercer JR; Wiebe LI; Kumar P; Somayaji VV; Chapman JD
J Nucl Biol Med (1991); 1992; 36(1):60-7. PubMed ID: 1450228
[TBL] [Abstract][Full Text] [Related]
52. Comparative preclinical evaluation of
Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
[TBL] [Abstract][Full Text] [Related]
53. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
54. Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
Deacon JM; Holliday SB; Ahmed I; Jenkins TC
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1087-90. PubMed ID: 3755713
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and radiosensitizing effect of PR-350.
Hirokawa K; Nakajima T; Tsumura M; Nishita T; Yamada R; Onoyama Y
Radiat Med; 1997; 15(1):45-9. PubMed ID: 9134584
[TBL] [Abstract][Full Text] [Related]
56. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
Denekamp J; Harris SR
Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
[No Abstract] [Full Text] [Related]
57. Multispectral photoacoustic imaging for the detection of subclinical melanoma.
Sinnamon AJ; Neuwirth MG; Song Y; Schultz SM; Liu S; Xu X; Sehgal CM; Karakousis GC
J Surg Oncol; 2019 Jun; 119(8):1070-1076. PubMed ID: 30874312
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
59. Zinc alpha-2-glycoprotein regulates melanin production by normal and malignant melanocytes.
Hale LP
J Invest Dermatol; 2002 Aug; 119(2):464-70. PubMed ID: 12190871
[TBL] [Abstract][Full Text] [Related]
60. Stimulation of melanin synthesis of B16-F10 mouse melanoma cells by bufalin.
Zhang L; Yoshida T; Kuroiwa Y
Life Sci; 1992; 51(1):17-24. PubMed ID: 1614270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
